当前位置: X-MOL 学术Therap. Adv. Gastroenterol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis.
Therapeutic Advances in Gastroenterology ( IF 4.2 ) Pub Date : 2023-06-12 , DOI: 10.1177/17562848231174290
Michal Prokopič 1 , Georgiana Gilca-Blanariux 2, 3 , Peter Lietava 4 , Anca Trifan 2, 3 , Anna Pietrzak 5 , Agata Ladic 6 , Marko Brinar 6 , Svetlana Turcan 7 , Tamás Molnár 8 , Peter Bánovčin 4 , Milan Lukáš 9
Affiliation  

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic immune-mediated diseases with a high incidence and prevalence in Europe. Since these are diseases with associated disability, they require complex management and the availability of high-quality healthcare resources. We focused on the analysis of IBD care in selected countries of Central and Eastern Europe (Croatia, the Czech Republic, Hungary, Moldova, Poland, Romania and Slovakia) targeting the availability and reimbursement of diagnostic and therapeutic modalities, the role of IBD centers and also education and research in IBD. As part of the analysis, we created a questionnaire of 73 statements organized in three topics: (1) diagnostics, follow-up and screening, (2) medications and (3) IBD centers. The questionnaire was filled out by co-authoring IBD experts from individual countries, and then the answers and comments on the questionnaire were analyzed. We identified that despite the financial burden, which still partially persists in the region, the availability of some of the cost-saving tools (calprotectin test, therapeutic drug monitoring) differs among countries, mainly due to variable reimbursement from country to country. In most participating countries, there also remains a lack of dedicated dietary and psychological counseling, which is often replaced by recommendations offered by gastroenterologists. However, there is adequate availability of most of the currently recommended diagnostic methods and therapies in each participating country, as well as the implementation of established IBD centers in the region.

中文翻译:

中欧和东欧炎症性肠病护理的障碍:区域特定分析。

炎症性肠病 (IBD),包括克罗恩病和溃疡性结肠炎,是慢性免疫介导的疾病,在欧洲发病率和流行率很高。由于这些是与残疾相关的疾病,因此需要复杂的管理和高质量医疗资源的可用性。我们重点分析了中欧和东欧选定国家(克罗地亚、捷克共和国、匈牙利、摩尔多瓦、波兰、罗马尼亚和斯洛伐克)的 IBD 护理,目标是诊断和治疗方式的可用性和报销、IBD 中心的作用和IBD 的教育和研究。作为分析的一部分,我们创建了一份包含 73 份陈述的问卷调查,分为三个主题:(1) 诊断、随访和筛查,(2) 药物治疗和 (3) IBD 中心。调查问卷由各国IBD专家共同填写,然后对调查问卷的回答和评论进行分析。我们发现,尽管经济负担在该地区仍然部分存在,但一些节省成本的工具(钙卫蛋白测试、治疗药物监测)的可用性因国家而异,这主要是由于各国的报销不同。在大多数参与国家中,还缺乏专门的饮食和心理咨询,这些咨询通常被胃肠病学家提供的建议所取代。但是,每个参与国都可以充分利用大多数目前推荐的诊断方法和疗法,并且在该地区建立了 IBD 中心。
更新日期:2023-06-12
down
wechat
bug